Cerner still king among EHR vendors

Cerner owns the greatest market share among electronic health record (EHR) vendors, topping competitors McKesson and Epic, while a number of smaller competitors are “thriving,” according to a Kalorama Information report.

The market share is based on 2016 revenue related to EHR hardware, software and services, such as consulting and training. The top three were unchanged from last year, with No. 1 Cerner being followed by second-ranked McKesson and No. 3 Epic. Allscripts came in fourth.

Below them were 600 other vendors, including Athenahealth, GE Healthcare and Meditech. The report said those companies could “disrupt the market” by taking advantage of changes in government policy and frustration from clinicians towards other vendors’ products.

"A few companies have more than half the market, but it's still true to say no company, not even the largest healthcare IT firms, have even a fifth of this market,"  Kalorama publisher Bruce Carlson said in a statement. "We think that is because there's still usability, vendor-switching, lack of mindshare in the market and customers are aching for better.  Healthcare still involves a lot of local markets and then with EMR there is a web opportunity to sell direct to smaller hospitals and physicians."

The rankings are separate from the latest EHR market share report from KLAS, which was based on purchasing decisions at hospitals with 200 or fewer beds. In that report, Epic was No. 1, followed by Cerner and Meditech.

As for grabbing the top spot in the Kalorama report, Cerner was praised for “continuing to add new business” in 2016 with products like Cerner ITWorks and Cerner RevWorks.

“The company is very strong in the hospital IT market,” the report said.

Also mentioned was Cerner landing a 10-year contract with the U.S. Department of Defense. More government business could be on the way, as a recent Black Book report named the company the most likely vendor for the U.S. Department of Veterans Affairs, assuming it decides to adopt a commercial EHR product. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.